The keystone of our research department is built on integrity, credibility and trust:

1. Akeman Allan Capital is adamant about providing the highest quality investment research. Akeman Allan Capital recognizes that individually and collectively, we are held accountable for our research consultancy and safe-guarding the integrity of our name.
2. Akeman Allan Capital endeavors' to be objective, insightful, financially rigorous, intelligible and timely.
3. Our research must always mirror the informed view of our research analysts. In developing our informed view, our analysts strive to be diligent and painstakingly detailed in their work, supporting their basis for opinions with appropriate levels of un-biased investigation, inquiry, analysis and judgment.
4. We recognize that potential conflicts of interest, either actual or perceived, may arise both internally within our firm as well as externally from corporate and investor clients. It is our responsibility to recognize and manage any conflict in a manner that shields our clients and our reputation.

Procedures for managing potential conflicts of interest are:

1. Akeman Allan Capital research team focuses on producing sound investment research reports.
2. Our Directors of Research are accessible by all analysts relative to any issue regarding actual or perceived conflict and/or inappropriate influences, whether from within or from outside sources.
3. Our Chief Director of Research is also the firm's designated Compliance Officer and reports directly to Akeman Allan Capital’s Board of Directors.

Supervision and management of analysts:

1. Analysts report directly to the top managers within their departments, and do not report to client corporate finance personnel or sales and trading personnel.
2. Analysts are permitted to fact check research drafts with the management of the subject company and with other client counter parties.
3. Prior to publication, the final research draft normally undergoes a twofold evaluation by an editor and a supervisory analyst. All research requires the Director’s consent preceding its publication.

Access to non-public information:

1. From time to time, Akeman Allan Capital’s analysts are privy to non public information. Akeman Allan Capital has recognized controls such that the analysts receiving this information do so within the guidelines of clear policies and procedures, which are designed to protect our client’s confidentiality and our name.
2. These procedures include notification and approval from the Director, the logging and reviewing of such approvals and the imposition of appropriate restrictions on the permitted activities of analysts concerned while the information remains non-public.

Akeman Allan Capital limits all analysts' involvement in portfolio management other than the diligent preparation of research:

1. Akeman Allan Capital’s analysts are not permitted to take part in sales presentations for corporate finance mandates for clients and are not permitted to make presentations or actively participate in road shows relating to a corporate finance transaction.
2. Analysts are permitted to carry out certain other roles where the firm feels that it would not conflict with their independence or the appearance thereof.
3. Discussing the merits of a proposed transaction with corporate finance clients
4. Discussing industry sector trends with corporate finance clients.
5. Assisting in due diligence.
6. Advising on market sentiment and pricing and structuring of securities offerings.
7. Investor education relating to a corporate finance transaction.
8. Participation in presentations at widely-attended conferences.

 

Back to Top